The relationship between the pharmaceutical industry and healthcare professionals, and healthcare organisations, plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
At the core of the relationship is sharing knowledge to improve outcomes for patients.
We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why, as part of a Europe-wide initiative, the UK pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to healthcare professionals, and healthcare organisations.
Alturix fully supports this approach, and publishes this information on the Disclosure UK database.
For 2019, this information was recorded under Atlantic Pharma. From 2020 onwards, this is recorded under Alturix.
Alturix works with UK patient organisations on projects and initiatives that ultimately benefit patients and their carers. In keeping with the principles of transparency outlined above, we publish an annual record of our support for these organisations which can be found here.
